Clinical Evidence Current clinical evidence for both peptides remains notably limited in comparison to the extensive body of preclinical data
The most commonly noted adverse event is transient nasal irritation, occasional mild headache, and rare dysgeusia (metallic taste) during or shortly after administration
For the internalization assay, cells were incubated with bacteria for 3 and 6 h at 37 C, after which the plates were washed three times with PBS to remove non-adherent bacteria
Most supporting data are preclinical or small uncontrolled human reports, and the marketed benefits should be read as hypotheses
This immunostimulatory effect of Spirulina may be attributed to its bioactive compounds like phycocyanin and polysaccharides
[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Peng B.J., Zhu Q., Zhong Y.L., Xu S.H., Wang Z